Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 156,700 | 97,200 | 42,500 | 153,800 | 183,100 |
| Depreciation Amortization | 65,500 | 44,000 | 21,400 | 81,600 | 60,000 |
| Income taxes - deferred | 5,400 | 3,000 | -1,300 | -8,700 | 18,800 |
| Accounts receivable | -38,000 | -41,300 | -53,800 | -37,600 | -50,100 |
| Accounts payable and accrued liabilities | 13,300 | 2,800 | 14,500 | 29,200 | 22,400 |
| Other Working Capital | -60,300 | -70,400 | -45,100 | -85,300 | -88,900 |
| Other Operating Activity | 14,200 | 33,500 | 35,800 | 130,400 | 26,700 |
| Operating Cash Flow | $156,800 | $68,800 | $14,000 | $263,400 | $172,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -96,900 | -64,300 | -33,900 | -220,800 | -170,300 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -100 |
| Investing Cash Flow | $-96,900 | $-64,300 | $-33,900 | $-220,800 | $-170,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2,900 |
| Debt Issued | 500 | N/A | 200 | 251,400 | 1,300 |
| Debt Repayment | -900 | -600 | -100 | -246,400 | -400 |
| Common Stock Issued | 9,900 | 7,700 | 6,200 | 15,400 | 14,300 |
| Common Stock Repurchased | N/A | N/A | N/A | -50,000 | N/A |
| Dividend Paid | -26,800 | -17,800 | -8,900 | -26,900 | -17,900 |
| Other Financing Activity | 3,800 | 2,700 | 2,200 | 7,900 | 6,700 |
| Financing Cash Flow | $-13,500 | $-8,000 | $-400 | $-48,600 | $6,900 |
| Exchange Rate Effect | -9,400 | -7,200 | -6,300 | -11,900 | -7,700 |
| Beginning Cash Position | 133,900 | 133,900 | 133,900 | 151,800 | 151,800 |
| End Cash Position | 170,900 | 123,200 | 107,300 | 133,900 | 152,600 |
| Net Cash Flow | $37,000 | $-10,700 | $-26,600 | $-17,900 | $800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 156,800 | 68,800 | 14,000 | 263,400 | 172,000 |
| Capital Expenditure | -96,900 | -64,300 | -33,900 | -220,800 | -170,300 |
| Free Cash Flow | 59,900 | 4,500 | -19,900 | 42,600 | 1,700 |